4/A//SEC Filing
Makker Gotham 4/A
Accession 0001140361-24-029438
CIK 0001281895other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 10:34 AM ET
Size
6.6 KB
Accession
0001140361-24-029438
Insider Transaction Report
Form 4/AAmended
Makker Gotham
Director
Transactions
- Sale
Common Stock
2024-03-21$28.43/sh−274,000$7,790,943→ 365,912 total(indirect: By Simran Investment Group)
Holdings
- 621,500(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein.
- [F2]This Form 4 corrects an error on the original Form 4 filed on March 25, 2024, which omitted shares of the issuer's common stock held by a non-revocable trust for the benefit of the reporting person's children that should have been included on the original Form 4.
- [F3]The securities may be deemed to be beneficially owned by the reporting person and are held by a non-revocable trust for the benefit of the reporting person's children. The reporting person has no voting or investment power over all securities owned by the trust.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001726391
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 10:34 AM ET
- Size
- 6.6 KB